Validation of a Multi-Omic Biosignature in a Multi-Institutional Cohort to Predict Locoregional Recurrence Risk and Differential RT Effect in Early-Stage Invasive Breast Cancer
Document Type
Conference Proceeding
Publication Date
9-2026
Publication Title
International Journal of Radiation Oncology, Biology, Physics
Volume
126
Issue
1 Suppl
First Page
S166
Last Page
S177
Recommended Citation
Khan AJ, Mann GB, Liefers GH, Bouwman L, Rebattu V, Li W, et al. [Vicini FA]. Validation of a multi-omic biosignature in a multi-institutional cohort to predict locoregional recurrence risk and differntial RT effect in early-stage invasive breast cancer. Int J Radiat Oncol Biol Phys. 2026 Sep;126(1 Suppl):S166-S167. doi:10.1016/j.ijrobp.2026.06.265
DOI
10.1016/j.ijrobp.2026.06.265
COinS
Comments
American Society for Radiation Oncology (ASTRO) 68th Annual Meeting, September 26-30, 2026, Boston, MA